Effects of acute and chronic L-arginine treatment in experimental hyperuricemia (Q39341867)

11 September 2017

Effects of acute and chronic L-arginine treatment in experimental hyperuricemia (English)

1 reference

11 September 2017

Tomás Nepomuceno

4

0 references

Martha Franco

object named as

Martha Franco

10

0 references

Takahiko Nakagawa

7

object named as

Takahiko Nakagawa

1 reference

11 September 2017

2

Edilia Tapia

1 reference

11 September 2017

5

Virgilia Soto

1 reference

11 September 2017

6

Carmen Avila-Casado

1 reference

11 September 2017

Laura G Sánchez-Lozada

1

1 reference

11 September 2017

Rubén López-Molina

3

1 reference

11 September 2017

Richard J Johnson

8

1 reference

11 September 2017

Jaime Herrera-Acosta

9

1 reference

11 September 2017

26 December 2006

1 reference

American Journal of Physiology - Renal Physiology

11 September 2017

1 reference

11 September 2017

292

1 reference

11 September 2017

F1238-44

1 reference

11 September 2017

4

1 reference

The clinical pharmacology of L-arginine

11 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Allopurinol improves endothelial dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Hyperuricemia in childhood primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Nitric oxide modulates vascular disease in the remnant kidney model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

A role for uric acid in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Hyperuricemia induces endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Regulation of hepatic connexins in cholestasis: possible involvement of Kupffer cells and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

A causal role for uric acid in fructose-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Hyperuricemia causes glomerular hypertrophy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Mild hyperuricemia induces glomerular hypertension in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Determination of serum protein concentration in nanoliter blood samples using fluorescamine or o-phthalaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Quantifying the L-arginine paradox in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Hyperuricaemia does not impair cardiovascular function in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

Uric acid and endothelial dysfunction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00164.2006

10.1152/AJPRENAL.00164.2006

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference